Total Payments
$1,541
2024 Payments
$427.15
Companies
12
Transactions
45
Medicare Patients
228
Medicare Billing
$42,189
Payment Breakdown by Category
Food & Beverage$1,483 (96.2%)
Education$54.99 (3.6%)
Travel$3.33 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,483 | 43 | 96.2% |
| Education | $54.99 | 1 | 3.6% |
| Travel and Lodging | $3.33 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $479.95 | 24 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $208.84 | 6 | $0 (2024) |
| Lilly USA, LLC | $161.30 | 2 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $154.66 | 3 | $0 (2023) |
| Arcutis Biotherapeutics, Inc. | $121.55 | 1 | $0 (2023) |
| GENZYME CORPORATION | $111.81 | 1 | $0 (2021) |
| Noctrix Health, Inc. | $94.63 | 1 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $92.31 | 1 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $45.88 | 2 | $0 (2022) |
| Merck Sharp & Dohme LLC | $34.68 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $427.15 | 8 | Lilly USA, LLC ($161.30) |
| 2023 | $345.20 | 7 | IDORSIA PHARMACEUTICALS US INC ($154.66) |
| 2022 | $256.75 | 8 | Janssen Scientific Affairs, LLC ($92.31) |
| 2021 | $252.42 | 7 | GENZYME CORPORATION ($111.81) |
| 2020 | $17.50 | 1 | Harmony Biosciences LLC ($17.50) |
| 2019 | $241.87 | 14 | JAZZ PHARMACEUTICALS INC. ($225.71) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Noctrix Health, Inc. | NIDRA (Device) | Food and Beverage | Cash or cash equivalent | $94.63 | General |
| Category: Restless Leg Syndrome | ||||||
| 08/05/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Education | Cash or cash equivalent | $54.99 | General |
| Category: Narcoplepsy | ||||||
| 07/31/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $27.17 | General |
| Category: Narcoplepsy | ||||||
| 07/11/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $157.97 | General |
| Category: Immunology | ||||||
| 07/11/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Travel and Lodging | Cash or cash equivalent | $3.33 | General |
| Category: Immunology | ||||||
| 06/12/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: NEUROLOGY | ||||||
| 05/15/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $39.68 | General |
| Category: Narcoplepsy | ||||||
| 01/24/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: NEUROLOGY | ||||||
| 08/16/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: INSOMNIA | ||||||
| 07/19/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: NEUROLOGY | ||||||
| 05/03/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Neurology | ||||||
| 03/16/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $113.46 | General |
| Category: INSOMNIA | ||||||
| 03/09/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $121.55 | General |
| 02/09/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: NEUROLOGY | ||||||
| 01/25/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: INSOMNIA | ||||||
| 11/03/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: NEUROLOGY | ||||||
| 08/24/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2022 | Harmony Biosciences LLC | Wakix (Drug) | Food and Beverage | Cash or cash equivalent | $27.29 | General |
| Category: Neurological Disorders | ||||||
| 07/27/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: NEUROLOGY | ||||||
| 07/01/2022 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $92.31 | General |
| Category: Immunology | ||||||
| 04/13/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: NEUROSCIENCE | ||||||
| 02/25/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: NEUROLOGY | ||||||
| 01/26/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $21.48 | General |
| Category: PSYCHOLOGY | ||||||
| 11/03/2021 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: NEUROLOGY | ||||||
| 10/27/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $24.40 | General |
| Category: PSYCHOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 50 | 60 | $19,489 | $8,905 |
| 2022 | 4 | 108 | 140 | $35,423 | $19,668 |
| 2021 | 3 | 70 | 95 | $21,958 | $13,616 |
Total Patients
228
Total Services
295
Medicare Billing
$42,189
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 36 | $11,907 | $5,506 | 46.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $4,660 | $2,073 | 44.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 13 | $2,921 | $1,326 | 45.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 43 | 70 | $17,193 | $11,006 | 64.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $9,753 | $5,485 | 56.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 23 | $4,128 | $2,531 | 61.3% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 17 | 17 | $4,350 | $646.65 | 14.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 27 | 52 | $11,855 | $8,271 | 69.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 24 | 24 | $7,803 | $4,606 | 59.0% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2021 | 19 | 19 | $2,300 | $738.53 | 32.1% |
About Dr. Robert Lebby, MD
Dr. Robert Lebby, MD is a Pulmonary Disease healthcare provider based in Aliso Viejo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457344129.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Lebby, MD has received a total of $1,541 in payments from pharmaceutical and medical device companies, with $427.15 received in 2024. These payments were reported across 45 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,483).
As a Medicare-enrolled provider, Lebby has provided services to 228 Medicare beneficiaries, totaling 295 services with total Medicare billing of $42,189. Data is available for 3 years (2021–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Sleep Medicine
- Location Aliso Viejo, CA
- Active Since 08/26/2005
- Last Updated 08/24/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457344129
Products in Payments
- XYWAV (Drug) $216.96
- XYREM (Drug) $163.71
- OLUMIANT (Drug) $161.30
- QUVIVIQ (Drug) $154.66
- WAKIX (Drug) $121.84
- DUPIXENT (Biological) $111.81
- SUNOSI (Drug) $99.28
- NIDRA (Device) $94.63
- TREMFYA (Drug) $92.31
- Wakix (Drug) $87.00
- QELBREE (Drug) $45.88
- BELSOMRA (Drug) $34.68
- Sunosi (Drug) $19.12
- Horizant (Drug) $16.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.